Information Provided By:
Fly News Breaks for January 30, 2020
DHR
Jan 30, 2020 | 12:17 EDT
Piper Sandler analyst William Quirk raised his price target for Danaher to $174 from $142 and keeps a Neutral rating on the shares following the company's Q4 results. Danaher continues to execute very well across its portfolio and is already raising its accretion estimates for GE Biosciences, Quirk tells investors in a research note. The analyst, who cites valuation for his Neutral rating, also believes the company's 2020 guidance is conservative and "ripe for upside."